Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health condition. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results may vary.
Back pain is not listed as a common side effect of Zepbound, Mounjaro, Wegovy or Ozempic: none of their adverse reactions tables include it. But every one of these labels names one kind of pain that involves the back as a warning sign: severe pain in the stomach area that will not go away and may spread to the back can mean acute pancreatitis, and it needs a call to your healthcare provider right away.
So the first question is not "is my back sore?" but "does this start in my belly?"
Stop and call if the pain starts in your belly
The Zepbound label tells patients that the symptoms of acute pancreatitis are "severe abdominal pain that may radiate to the back, and which may or may not be accompanied by nausea or vomiting," and instructs them to stop Zepbound promptly and contact their healthcare provider if pancreatitis is suspected. The Mounjaro, Saxenda and Rybelsus labels carry the same warning. The Wegovy and Ozempic Medication Guides put it in plain words: call your healthcare provider right away if you have severe pain in your stomach area that will not go away, with or without vomiting. "You may feel the pain from your abdomen to your back."
In the two pooled Zepbound weight-reduction trials, acute pancreatitis confirmed by adjudication was rare: 0.2% of people on Zepbound and 0.2% on placebo. The label also records fatal cases with GLP-1 receptor agonists, so this is a symptom to act on, not to watch.
Seek urgent care if you have:
- Severe or persistent belly pain, with or without pain spreading to the back
- Belly pain with vomiting, or you cannot keep fluids down
- Pain in the upper right or middle upper belly, fever, yellow skin or eyes, or clay-colored stools (gallbladder warning signs)
Does Zepbound cause back pain? What the labels say
From the current US prescribing information for each drug:
| Back pain in the adverse reactions table? | Abdominal pain (drug vs placebo) | Pancreatitis warning mentions the back? | |
|---|---|---|---|
| Zepbound (tirzepatide) | Not listed in the label's common adverse reactions table (Table 1) | 9% (5 mg), 9% (10 mg), 10% (15 mg) vs 5% | Yes (5.5, 17) |
| Mounjaro (tirzepatide) | Not listed in the label's common adverse reactions table (Table 1) | 6% (5 mg), 5% (10 mg), 5% (15 mg) vs 4% | Yes (5.2, 17) |
| Wegovy (semaglutide) | Not listed in the label's common adverse reactions table (Table 3) | 20% vs 10% | Yes (5.2, Medication Guide) |
| Ozempic (semaglutide) | Not listed in the label's common adverse reactions table (Table 1) | 7.3% (0.5 mg), 5.7% (1 mg) vs 4.6% | Yes (5.2, Medication Guide) |
Back pain did not make any of these lists. Abdominal pain did, on every drug, and the dangerous patterns on this page start in the abdomen.
The Mounjaro and Ozempic numbers come from trials in type 2 diabetes; the Zepbound and Wegovy numbers come from weight-reduction trials. Compare within a row, not across drugs.
Why might back pain show up on a GLP-1?
No label describes back pain as a direct effect of tirzepatide or semaglutide. Three label warnings can involve pain near the back, and there are everyday causes too.
Pancreatitis. Covered above. The label wording is pain in the abdomen that may radiate to the back.
Gallbladder disease. The Zepbound label says treatment with Zepbound and GLP-1 receptor agonists "is associated with an increased occurrence of acute gallbladder disease." In the pooled weight-reduction trials, cholecystitis (gallbladder inflammation) was reported in 0.7% of people on Zepbound vs 0.2% on placebo, and "acute gallbladder events were associated with weight reduction." The semaglutide Medication Guides list the symptoms: pain in your upper stomach, fever, yellowing of skin or eyes, and clay-colored stools. MedlinePlus places gallstone pain in the right upper or middle upper abdomen, and the NHS tells people to go to the emergency department for pain that spreads from the tummy to the back with vomiting.
Kidney problems from dehydration. The labels warn that nausea, vomiting and diarrhea can cause fluid loss (dehydration) that may lead to kidney problems. In the Zepbound trials, acute kidney injury was reported in 0.5% of people on Zepbound vs 0.2% on placebo. The label does not describe back pain as a symptom of this; the point is fluids. If you are losing them faster than you can replace them, call your provider.
Everyday causes. The US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) lists muscle and tendon strains, tight muscles that support the spine, and disc problems as common causes of back pain. It also notes that back pain is "more likely if you exercise too strenuously after being inactive for a while." If you started walking or lifting more along with your GLP-1, a new routine is worth considering. The labels do not address whether weight loss itself changes back pain.
When does it start, and how long does it last?
The labels give no timeline for back pain, because back pain is not a listed side effect. What the Zepbound label does say is that most nausea, vomiting and diarrhea happen during dose escalation and decrease over time, and that the kidney risk deserves the most attention during the start and each dose increase. If back pain comes with stomach symptoms, note when each started relative to your shot.
For back pain on its own, NIAMS says to see a doctor if it does not improve after a few weeks.
What helps with ordinary back pain?
Once urgent causes are ruled out, these general steps come from NIAMS guidance. Agree on them with your clinician:
- Stay gently active instead of resting in bed, and increase activity gradually as tolerated.
- Build new exercise up slowly. Ask your doctor or a physical therapist which exercises suit you.
- Break up long sitting. Get up, move around and change positions often.
- Lift with your legs, not your back, and avoid heavy lifting where you can.
- Keep fluids up, especially on days with nausea, vomiting or diarrhea. This protects your kidneys. See GLP-1 dizziness for more on dehydration signs.
- Ask your prescriber before taking any pain reliever, including over-the-counter products. Never skip, delay or change a GLP-1 dose on your own.
When to call your doctor about back pain
Beyond the urgent signs at the top of this page, NIAMS lists these reasons to see a doctor for back pain:
- Pain that does not improve after a few weeks
- Numbness and tingling, or weakness, pain or numbness in the legs
- Severe pain that does not improve with medication
- Back pain after a fall or injury
- Trouble urinating
- Fever
- Unintended weight loss (tell your clinician you are on a GLP-1, since weight loss is expected)
What to track, and why it helps
Your clinician will ask where the pain started and what came with it. A log answers that better than memory. In the GLP AI app, back pain is not a catalog item, so add it as a custom symptom and give each entry a severity from 1 to 10. "Stomach pain" is a catalog item: log it separately, because belly pain plus back pain is the pattern the labels warn about. Your dose log sits on the same timeline, and the estimated medication level chart shows where each symptom falls in your dose week. Before an appointment, you can export a doctor report PDF with your medication history, side effects and weight over time and share it yourself. The GLP-1 symptom tracker and doctor visit prep pages explain how.
For the full side-effect lists, see Zepbound side effects, Wegovy side effects or the GLP-1 side effects hub.
Back Pain on GLP-1 FAQ
Can Zepbound cause back pain?
Back pain is not in Zepbound's common adverse reactions table. But the label warns that severe abdominal pain that may radiate to the back can be a sign of acute pancreatitis. If your pain starts in your belly, or is severe and persistent, contact your healthcare provider right away.
Is back pain a sign of pancreatitis on Zepbound or Ozempic?
The labels describe pancreatitis pain as persistent or severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting. Back pain on its own does not match that description, but it does not rule pancreatitis out either. If the pain is severe, keeps getting worse, or comes with nausea, vomiting or fever, contact your prescriber or get urgent care.
Does Ozempic cause back pain?
Back pain is not in the Ozempic or Wegovy common adverse reactions tables. Their Medication Guides say pancreatitis pain is severe stomach pain that will not go away, and that you may feel it from your abdomen to your back.
Can tirzepatide cause lower back pain?
Neither tirzepatide label (Zepbound or Mounjaro) lists lower back pain as a common side effect. Common causes include muscle strain, disc problems and overdoing exercise after inactivity. If it does not improve in a few weeks, or comes with leg numbness, fever or trouble urinating, see a doctor.
Should I stop my GLP-1 if my back hurts?
Do not change your dose on your own. The labels tell patients to stop and call their provider if pancreatitis is suspected, meaning severe belly pain that may spread to the back. For other back pain, contact your prescriber and let them decide.
Sources verified 2026-10-26
- Zepbound prescribing information (USPI, revised 08/2026): Table 1 (back pain not listed; abdominal pain 9/9/10% vs 5%), sections 5.3 to 5.5, 6.1 and 17.
- Mounjaro prescribing information (USPI, revised 08/2026): Table 1, section 5.2 and 17.
- Wegovy prescribing information and Medication Guide (revised 06/2026): Table 3, section 5.2 and Medication Guide.
- Ozempic prescribing information and Medication Guide (revised 05/2026): Table 1, section 5.2 and Medication Guide.
- Saxenda prescribing information and Rybelsus prescribing information: section 5.2 pancreatitis wording.
- NIAMS: Back Pain and Back Pain: Diagnosis, Treatment, and Steps to Take.
- MedlinePlus: Gallstones.
- NHS: Gallstones.
GLP AI
Editorial
Educational content from the GLP AI team about living on a GLP-1. Clinical review is credited by name on pages a reviewer has checked. Not medical advice.
More GLP-1 side effects
- Nausea & vomitingGLP-1 nausea is the most common side effect: 25–29% on Zepbound and 44% on Wegovy vs 8–16% on placebo. Why it happens, how long it lasts, what helps.
- ConstipationGLP-1 constipation: 11–24% of people on Zepbound or Wegovy in weight-loss trials vs 5–11% on placebo. Fiber and fluid targets, what helps, when to call.
- DiarrheaHow common it is on Zepbound, how long it lasts, what helps and when to call.
- Hair lossGLP-1 hair loss is in the labels: 4–5% on Zepbound and 3% on Wegovy 2.4 mg, vs 1% on placebo. Why it happens, when it regrows, and when to call.
- Fatigue & tirednessDoes GLP-1 make you tired? Fatigue is a labeled side effect: 5–7% on Zepbound, 11% on Wegovy, vs 3–5% on placebo. Causes, what helps, when to call.
- Muscle loss & muscle painGLP-1 muscle loss: about a quarter of the weight lost on tirzepatide in trials was lean mass. How protein and strength training help, and muscle pain.
- Injection site reactionsA Zepbound injection site reaction (redness, itching, bruising) affected 6–8% of people vs 2% on placebo. What helps, and the allergy signs that need care.
- HeadacheTirzepatide headache: Zepbound and Mounjaro labels don't list it; Wegovy lists 14% vs 10% on placebo. Common triggers, what helps, when to get help.
- Sulfur burpsSulfur burps on Wegovy, Ozempic, Zepbound or Mounjaro: belching is in every label (up to 7% vs under 1% on placebo). Why, what helps, when to call.
- Insomnia & sleepZepbound insomnia: the label does not list it as a common side effect. What can keep you up on a GLP-1, what helps, and when to call your doctor.
- DizzinessGLP-1 dizziness is a labeled side effect: 8% on Wegovy vs 4% on placebo, 4–5% on Zepbound vs 2%. Common causes to rule out, what helps, when to call.
- Period changesGLP-1 and periods: no label lists cycle changes, but tirzepatide can make the pill less effective. What each label says, and when to call.
- Mood, anxiety & depressionCan tirzepatide cause anxiety? Its labels don't list anxiety or depression, and a 2026 FDA review found no added risk. What to know and when to get help.